miR-122通过靶向RUNX2诱导胶质瘤细胞凋亡的实验研究

临床肿瘤学杂志 ›› 2019, Vol. 24 ›› Issue (2): 124-128.

miR-122通过靶向RUNX2诱导胶质瘤细胞凋亡的实验研究

1 610100 成都四川省医学科学院四川省人民医院神经内科

2 610100 四川省医学科学院四川省人民医院（东院）肿瘤内科

收稿日期:2018-11-02 修回日期:2019-01-06 出版日期:2019-02-28 发布日期:2019-03-18

MiR-122 induces apoptosis of glioma cells by targeting RUNX2

Department of Neurology， Sichuan People’s Hospital， Sichuan Academy of Medical Sciences， Chengdu 610100， China

Received:2018-11-02 Revised:2019-01-06 Online:2019-02-28 Published:2019-03-18

摘要/Abstract

摘要：

目的探讨微小RNA122（miR-122）对神经胶质瘤细胞凋亡的影响及可能分子机制。方法采用荧光定量PCR（QPCR）检测人正常星形胶质细胞系HA1800和胶质瘤细胞系U251、U87、SHG44、MO59K中miR-122的表达情况。双荧光素酶报告实验评价miR-122对RUNX2的靶向调控作用。向U251细胞转染miR-122 mimics（miR-122组）和阴性对照NC（NC组），流式细胞术检测细胞凋亡，Western blotting检测凋亡相关蛋白Bcl-2、Bax、cleaved caspase-3的表达。向U251细胞同时转染miR-122 mimics和siRUNX2（miR-122+siRUNX2组），流式细胞术检测细胞凋亡。结果 U251、U87、SHG44、MO59K细胞系中miR-122表达水平分别为0.34±0.052、0.65±0.061、0.59±0.071和0.69±0.098，显著低于正常星形胶质细胞系HA1800的1.17±0.173，差异具有统计学意义（P＜0.05）。miR-122可抑制野生型RUNX2 3’UTR报告基因载体的荧光素酶活性，而对突变型RUNX2 3’UTR-MUT的荧光素酶活性无影响。miR-122组U251细胞凋亡率为（23.77±0.83）％，高于NC组的（6.17±0.12）％，差异具有统计学意义（P＜0.05）；低于miR-122+siRUNX2组的（70.85±0.35）％（P＜0.05）。Western blotting检测结果显示，miR-122组RUNX2蛋白表达量为0.57±0.048，低于NC组的1.21±0.19（P＜0.05）。与NC组比较，miR-122组Bax（3.47±0.077）、 cleaved caspase-3（4.38±0.121）表达均明显上调，而Bcl-2（0.39±0.104）明显下调（P＜0.05）。结论 miR-122可以通过靶向RUNX2促进线粒体凋亡通路的激活，促进神经胶质瘤细胞凋亡。

关键词:

神经胶质瘤')">"> 神经胶质瘤, miR-122, RUNX2, 凋亡

Abstract: Objective To investigate the effect of microRNA122 （miR-122） on apoptosis of glioma cells and its possible molecular mechanism. Methods The expression of miR-122 in human normal astrocyte lines HA1800 and glioma cell lines U251， U87， SHG44 and MO59K was detected by quantitative fluorescence PCR （QPCR）. Dual luciferase reporter assay was used to evaluate the targeting effect of miR-122 on RUNX2. MiR-122 mimics （miR-122 group）and negative control NC（NC group） were transfected into U251 cells. Apoptosis was detected by flow cytometry. Western blotting was used to detect the expression of Bcl-2，Bax and cleaved caspase-3 protein in two groups. MiR-122 mimics and siRUNX2 （MiR-122+siRUNX2 group） were simultaneously transfected into U251 cells. Apoptosis was detected by flow cytometry. Results The expression of miR-122 in U251，U87，SHG44 and MO59K cell lines were 0.34±0.052， 0.65±0.061， 0.59±0.071 and 0.69±0.098， which was significantly lower than that of human normal astrocyte lines HA1800 （1.17±0.173）， and the difference was statistically significant （P＜0.05）.MiR-122 inhibited the luciferase activity of wild-type RUNX2 3’UTR reporter gene vector， but had no effect on the luciferase activity of mutant RUNX2 3’UTR reporter gene vector. The apoptotic rate of U251 cells in miR-122 group was （23.77 ±0.83）％， higher than that in NC group （6.17 ±0.12）％， lower than that in miR-122+siRUNX2 group （70.85±0.35）％.The difference was statistically significant （P＜0.05）. Western blotting Results showed that the expression of RUNX2 protein in the miR-122 group was 0.57±0.048， which was lower than that in the NC group （1.21±0.19）， with statistical significance （P＜0.05）. Compared with NC group， the expressions of Bax and cleaved caspase-3 were significantly up-regulated in miR-122 group， while Bcl-2 was significantly down-regulated （P＜0.05）. Conclusion MiR-122 can promote the activation of mitochondrial apoptosis pathway by targeting RUNX2， thereby promoting apoptosis of glioma cells.

Key words: Glioma, miR-122, RUNX2, Apoptosis

中图分类号:

R739.41

杨才弟, 王丽娟, 曾鼎华, 朱剑梅.

miR-122通过靶向RUNX2诱导胶质瘤细胞凋亡的实验研究 [J]. 临床肿瘤学杂志, 2019, 24(2): 124-128.

YANG Caidi, WANG Lijuan, ZENG Dinghua, ZHU Jianmei..

MiR-122 induces apoptosis of glioma cells by targeting RUNX2 [J]. Chinese Clinical Oncology, 2019, 24(2): 124-128.

参考文献

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

本文评价

推荐阅读 10

[1]	钟克力¹，张　丽²，戴　勇²，周汉新²，王春友¹. 采用染色质免疫沉淀联合芯片技术分析胃癌全基因组蛋白Ｈ３Ｋ２７三甲基化水平[J]. 临床肿瘤学杂志, 2009, 14(1): 15 .
[2]	钱　莘¹，丁金勇²，吕　军¹，陈正堂². ＣＣＡ＋ＳＰ-Ｃ＋细胞和ＣＤ１３３＋细胞在人肺腺癌组织分布的初步研究[J]. 临床肿瘤学杂志, 2009, 14(1): 6 .
[3]	杨　斌，陈赛英，史佃云，张佃乾. 宫颈癌术前介入化疗前后组织中Ｓｕｒｖｉｖｉｎ、Ｃａｓｐａｓｅ-３和Ｃａｓｐａｓｅ-７的表达变化及意义[J]. 临床肿瘤学杂志, 2009, 14(1): 39 .
[4]	侯　军，章卫平，邱慧颖，郑晓丽，王利平，倪　雄，宋献民，王健民. 自体外周血干细胞移植治疗Ｔ细胞淋巴瘤的临床研究[J]. 临床肿瘤学杂志, 2009, 14(2): 102 .
[5]	陈　建^1,许　林¹. 局部晚期非小细胞肺癌的外科治疗现状[J]. 临床肿瘤学杂志, 2009, 14(2): 183 .
[6]	刘扬清¹，高　勇¹，万一元¹，易竹筠¹，惠红霞¹，徐丽娟¹，刘　华¹. 大蒜素对结肠癌ＬｏＶｏ细胞增殖的影响[J]. 临床肿瘤学杂志, 2009, 14(2): 139 .
[7]	李建军，黄海辉，潘　凤，边志衡，胡绍毅，梁后杰. 透明质酸酶增强５-ＦＵ对结肠癌抗癌作用的动物实验研究[J]. 临床肿瘤学杂志, 2009, 14(2): 134 .
[8]	时淑珍¹，赵俊军²，赵卫红¹，徐晓辉¹. ＦＨＩＴ和ｍｄｍ２蛋白在非小细胞肺癌中的表达及意义[J]. 临床肿瘤学杂志, 2009, 14(3): 212 .
[9]	王乐纯¹，杨　强²，马成海¹. 小儿骶尾部畸胎瘤的手术治疗[J]. 临床肿瘤学杂志, 2009, 14(3): 242 .
[10]	何义富，孙玉蓓，陈　健，徐腾云，王　刚，王　勇，杜建平，陈曼萍，江丰收，胡长路，季楚舒，胡　冰. 腹腔内应用重组人血管内皮抑制素联合氟尿嘧啶治疗恶性腹水的初步探讨[J]. 临床肿瘤学杂志, 2009, 14(3): 252 .